HESTERBIO
NSEHester Biosciences Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,952.90
7.00 (0.36%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.66K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
32.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,239.3+57.6%
52W High₹2,350-16.9%
Current Price
₹1,952.90
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,562.32
Upper Circuit₹2,343.48
Reference Price
₹1,952.90
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1995.9
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1995.9
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
80%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1906.68
EMA50
1764.85
EMA200
1701.27
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹1990.00
₹2070.00
₹2176.00
₹2238.70
₹2350.00
Support (Below)
₹1910.20
₹1883.10
₹1799.00
₹1774.00
₹1749.00
Volume Analysis
TrendDECREASING
Change-87.30%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1933.37
3% Risk₹1894.31
5% Risk₹1855.26
7% Risk (Custom)
₹1816.20Technical Levels
1x ATR (Volatility)₹1858.30
2x ATR (Swing)₹1763.70
3x ATR (Trend)₹1669.10
Immediate Support₹1910.20
Moving Averages
EMA 9 (Short-term)₹1952.37
EMA 20 (Medium-term)₹1906.68
EMA 50 (Trend)₹1764.85
EMA 200 (Long-term)₹1701.27
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹81.9 Cr | ₹84.1 Cr | ₹71 Cr | ₹77.4 Cr |
| Net Profit | ₹1.3 Cr | ₹16.4 Cr | ₹14.4 Cr | ₹8.8 Cr |
| EPS | — | ₹20.33 | ₹16.85 | ₹10.94 |
| Operating Profit | ₹9.2 Cr | ₹26.2 Cr | ₹23.6 Cr | ₹19.8 Cr |
ROE
8.75%
ROCE
9.08%
Debt/Equity
0.68
Current Ratio
1.56
OPM
25.55%
NPM
11.32%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 06 Aug 2025 | Dividend - Rs 7 Per Share | DIVIDEND |
| 22 Aug 2024 | Dividend - Rs 6 Per Share | DIVIDEND |
| 22 Aug 2024 | Annual General Meeting | AGM |
| 13 Sept 2023 | Annual General Meeting/Dividend - Rs 8 Per Share | AGM |
| 11 Aug 2022 | Annual General Meeting/Dividend - Rs 10 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for HESTERBIO
View AllNEWS
positive
Business Standard - Markets 29d ago
Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter
Sales rise 22.19% to Rs 100.11 crore
HESTERBIOHealthcare
NEWS
neutral
Business Standard - Markets 29d ago
Noida Toll Bridge Company Ltd leads gainers in 'B' group
Mahalaxmi Fabric Mills Ltd, NRB Industrial Bearings Ltd, Hester Biosciences Ltd and Hybrid Financial Services Ltd are among the other gainers in the BSE's 'B' group today, 15 May 2026.
BSEHESTERBIOHYBRIDFINJMFINANCILMFMLNIBLNOIDATOLLCapital GoodsFinancial Services
positive
CNBC TV18 - Markets 29d ago
Hester Biosciences Q4 Results: Stock jumps 14% after profit growth, strong operating performance
Hester Biosciences' board has recommended a dividend of ₹11 per equity share for FY26, subject to shareholder approval at the upcoming annual general meeting.
ARSSBLDIVIDENDHESTERBIOFinancial ServicesHealthcare